2025-07-14 - Analysis Report
Okay, here's a report analyzing Procter & Gamble (PG) based on the data you provided.

## Procter & Gamble (PG) Stock Analysis

**Ticker:** PG
**Company:** Procter & Gamble Co.
**Description:** Procter & Gamble is a multinational consumer goods corporation that provides a wide range of branded consumer packaged goods.

### 1. Performance vs. S&P 500 (VOO)

*   **PG Cumulative Return:** 49.65%
*   **VOO Cumulative Return:** 95.46%
*   **Absolute Divergence (PG - VOO):** -45.81%
*   **Divergence Range:** Max: 29.9, Min: -45.8
*   **Relative Divergence:** 0.0

**Analysis:** PG has significantly underperformed the S&P 500 (VOO) over the period examined.  The current divergence is at the lowest point of its historical range, indicating substantial underperformance relative to the benchmark.

**Alpha/Beta Analysis (Yearly Rolling):**

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
|------------|---------|---------|---------|------|--------|
| 2015-2017  | 21.0%   | 7.9%    | -8.0%   | 0.0  | 211.6  |
| 2016-2018  | 5.0%    | 56.7%   | -13.0%  | 0.1  | 211.7  |
| 2017-2019  | 30.0%   | 56.7%   | 0.0%    | 0.5  | 287.6  |
| 2018-2020  | 38.0%   | 59.1%   | 18.0%   | 0.3  | 320.4  |
| 2019-2021  | 56.0%   | 59.1%   | 8.0%    | 0.3  | 376.7  |
| 2020-2022  | 24.0%   | 74.7%   | 22.0%   | 0.3  | 349.0  |
| 2021-2023  | 30.0%   | 74.7%   | 12.0%   | 0.3  | 337.4  |
| 2022-2024  | 8.0%    | 74.7%   | -17.0%  | 0.3  | 386.0  |
| 2023-2025  | -10.0%  | 71.6%   | -57.0%  | 0.2  | 361.6  |

**Analysis:**

*   **Alpha:** The alpha is negative for recent periods (2022-2024 and 2023-2025), indicating underperformance relative to the market, even after accounting for risk. The negative alpha in 2023-2025 is particularly pronounced.
*   **Beta:** The beta values are relatively low, suggesting PG is less volatile than the overall market.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) has decreased significantly in recent years, turning negative in the most recent period (2023-2025).
*   **MDD:** Maximum Drawdown is high and has been consistently elevated in recent periods, suggesting significant potential for loss during downturns.

### 2. Recent Price Action

*   **Current Price:** 157.05
*   **Last Market Data:** Price: 154.32, Previous Close: 157.05, Change: -1.74
*   **5-day Moving Average:** 158.29
*   **20-day Moving Average:** 159.60
*   **60-day Moving Average:** 162.28

**Analysis:**  The stock price is below all three moving averages, suggesting a short-term downtrend. The recent market data shows a decline (-1.74), indicating continued negative momentum.

### 3. Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3294 (Low Risk)
*   **RSI:** 43.31
*   **PPO:** -0.094
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (6 shares - Caution - MRI:0.34) (Cash Ratio: 0% on 2025-07-08)
*   **Recent (20-day) Relative Divergence Change:** 0.0 (-), 단기하락
*   **Expected Return:** 799.8%

**Analysis:**

*   **MRI:** The MRI suggests a low-risk environment, which may be misleading given the other indicators.
*   **RSI:** The RSI is below 50, indicating bearish momentum but not yet oversold conditions.
*   **PPO:** The negative PPO suggests a downtrend.
*   **Hybrid Signal:** The hybrid signal suggests a buy with caution due to the low MRI.
*   **Recent Relative Divergence Change:** Negative change in divergence confirms short-term bearish momentum.
*   **Expected Return:**  The very high expected return should be treated with skepticism.  It's an estimate based on a specific model and may not reflect reality.

### 4. Recent News & Significant Events

*   **2025-07-12:** Major business developments, regulatory changes, or market events.
*   **2025-07-14:** Analysts discussing recent performance and outlook.
*   **2025-07-13:** Notable volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-07-10:** Market experts highlight both risks and opportunities.

**Analysis:** Recent news suggests potential headwinds for PG, including volatility, regulatory changes, and market events. Investors should monitor company announcements and news closely.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출         |
|------------|------|--------------|
| 2025-04-24 | 1.58 | 19.78 B$      |
| 2025-01-22 | 1.94 | 21.88 B$      |
| 2024-10-18 | 1.65 | 21.74 B$      |
| 2024-04-19 | 1.56 | 20.20 B$      |
| 2025-04-24 | 1.56 | 20.20 B$      |

**Analysis:**

*   EPS has been variable, with a noticeable drop in the most recent quarter.
*   Revenue has also fluctuated, indicating inconsistent growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $19.78B   | 50.98%        |
| 2024-12-31   | $21.88B   | 52.39%        |
| 2024-09-30   | $21.74B   | 52.06%        |
| 2024-06-30   | $20.53B   | 49.60%        |
| 2024-03-31   | $20.20B   | 51.20%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE     |
|--------------|-----------|---------|
| 2025-03-31   | $52.27B   | 7.21%   |
| 2024-12-31   | $51.17B   | 9.05%   |
| 2024-09-30   | $51.84B   | 7.64%   |
| 2024-06-30   | $50.29B   | 6.24%   |
| 2024-03-31   | $50.06B   | 7.50%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has fluctuated, with a decrease in the latest quarter. Profit margins are generally high, suggesting strong cost control but potential sensitivity to revenue declines.
*   **Capital and Profitability:** Equity has shown modest growth. ROE has fluctuated, with a recent decline, suggesting lower returns on equity compared to previous periods.

### 7. 종합 Analysis & Conclusion

Procter & Gamble (PG) is currently facing several challenges.  It has significantly underperformed the S&P 500, with a negative alpha indicating underperformance even after accounting for risk. Recent price action shows a downtrend, with the stock trading below its moving averages.  Earnings and revenue have been variable, and recent news points to potential headwinds. While the MRI indicates low risk, other indicators like RSI and PPO suggest bearish momentum.  The very high "expected return" should be viewed cautiously.

**Overall, the analysis suggests caution regarding PG. Investors should carefully monitor upcoming earnings reports, news, and market conditions before making investment decisions.**

I hope this helps!
